Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Meitheal Pharmaceuticals Expands Its Specialty Biopharma Range by Acquiring CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics

Friday, July 19, 2024

Meitheal Pharmaceuticals Inc a biopharmaceutical company based in Chicago with a focus on generic injectables fertility treatments biologics and branded products has announced its acquisition

NMDP BioTherapies and the Cord Blood Bank Alliance Announce Enhanced Selection of Cord Blood Units for NK and Other Cell Therapies

Friday, July 19, 2024

NMDP BioTherapiesSM and the NMDP BioTherapies Cord Blood Bank Alliance which includes nine public cord blood banks are now providing preidentified cord blood units

Draupnir Bio Raises €12 Million in Seed Funding to Further Develop Oral Small Molecule Degraders Targeting Extracellular Proteins

Thursday, July 18, 2024

Draupnir Bio a biotechnology company has raised million in equity investments to advance its innovative approach in targeted protein degradation The company focuses on developing oral

Grünenthal Increases Investment in Latin America Production Facilities to Ensure Reliable Medicine Supply

Thursday, July 18, 2024

Grnenthal a leading pharmaceutical company specializing in pain research and management has recently announced significant investments in its Latin American production sites These investments

Genomics plc and Vertex Pharmaceuticals Extend and Expand Collaboration in Drug Discovery

Wednesday, July 17, 2024

Genomics plc has announced a further threeyear extension of its collaboration with Vertex Pharmaceuticals Incorporated to advance the discovery and development of precision medicines

Synamics Therapeutics Attracts Former Executives from Novozymes as Lead Investors for AI-Driven Drug Discovery

Wednesday, July 17, 2024

Synamics Therapeutics a startup focused on using AI for drug discovery to combat drug resistance in cancer has received significant backing in its preseed funding round from two prominent figures

Sionna Therapeutics Expands Cystic Fibrosis Pipeline with Multiple Clinical-Stage Compounds Through Collaboration with AbbVie

Wednesday, July 17, 2024

Sionna Therapeutics a company in the clinical stage of life sciences dedicated to advancing treatments for cystic fibrosis has recently secured exclusive global rights to develop

CordenPharma Plans €900 Million Investment to Enhance Peptide Platform in the USA and Europe

Tuesday, July 16, 2024

CordenPharma has recently announced its largest strategic investment totaling around million over the next three years aimed at expanding its Peptide technology platform This initiative includes significant

Catalent Completes Expansion of Clinical Supply Facility Worth $25 Million in Schorndorf, Germany

Tuesday, July 16, 2024

Catalent Inc has recently completed the expansion of its clinical supply facility located in Schorndorf Germany This expansion marks a significant upgrade to Catalents flagship European site adding square

Sumitomo Pharma Receives FDA Fast Track Designation for DSP-5336 in Relapsed or Refractory Acute Myeloid Leukemia Treatment

Monday, July 15, 2024

Sumitomo Pharma America Inc has announced that the US Food and Drug Administration granted Fast Track designation to DSP for the treatment of patients with relapsed or refractory

Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024